No one appears to contest the efficacy of his treatment; the problem, the film suggests, is a pharmaceutical industry with nothing to gain — and much to lose — from the introduction of a highly successful, nontoxic competitor to chemotherapy and radiation.
- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (3)
I don't usually seed movie reviews, but this is news to me. If these claims are true, why isn't it more well known?
At the center of the tangle is Dr. Stanislaw Burzynski, a Texas doctor and biochemist whose genetically oriented cancer therapy may have cured a variety of difficult-to-treat tumors. Until 1995, Texas law permitted Dr. Burzynski to administer his therapy without the approval of the Food and Drug Administration. A change in the law, however, catapulted the doctor into a 14-year battle to win that approval, a struggle that has caused him to question whose interests — the public’s or Big Pharma’s — the drug agency was instituted to serve.
- 5 votes
Glancing around it appears only Dr. Burzynski or his associates have been able to document the beneficial use of his treatment. Other cited studies to do so fail which is strange as to why it could work one place and not the other. There have been trials going on since 1977 on this so it's received a good bit of attention but inability to replicate gets it stuck every time.
- 2 votes
doesn't congress make quite a bit of money off of pharmaceuticals? The good Dr. would be in competition with them, too.
- 1 vote
You're in Easy Mode. If you prefer, you can use XHTML Mode instead. |



